Abstract:ObjectiveTo investigate the role of hepatic stellate cell (HSC) inflammation in the pathogenesis of acute-on-chronic liver failure (ACLF). MethodsA total of 45 male Kunming mice were randomly divided into control group, model group, and N-acetylcysteine (NAC) group. The mice in the model group and the NAC group were given injection of human serum albumin to establish a model of chronic liver disease, followed by intraperitoneal injection of the endotoxins lipopolysaccharide (LPS) and D-galactosamine (D-GlaN) to induce ACLF, and those in the control group were given injection of an equal volume of normal saline; the mice in the NAC group were given NAC since 1 week before the induction of NAC. The mice in the model group and the NAC group were sacrificed at 48 hours after the injection of LPS and D-GlaN. ELISA was used to measure the serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) and the levels of malondialdehyde (MDA) and superoxide dismutase (SOD) in liver tissue; HE staining was used to determine liver pathological score; ELISA was used to measure the serum levels of LPS and interleukin-1β (IL-1β). LX2 cells were stimulated by LPS and H2O2 with the presence or absence of NAC, and ELISA was used to measure the levels of IL-1β and interleukin-6 (IL-6) in medium. LX2 cells were stimulated by LPS and H2O2, and then HL7702 cells were cultured with LX2 medium; Western blot was used to measure the expression of caspase-3 and caspase-8 in HL7702 cells, and flow cytometry was used to measure the apoptosis of HL7702 cells. A one-way analysis of variance was used for comparison of continuous data between multiple groups; the least significant difference t-test was used for comparison of data with homogeneity of variance between two groups, and the Tamhane’s T2 test was used for comparison of data with heterogeneity of variance. The Kaplan-Meier survival analysis was used to evaluate survival time, and the log-rank test was used for comparison. ResultsAt 48 hours, all mice in control group survived, while 3 mice in the model group and 8 mice in the NAC group survived, suggesting that the NAC group had a better survival rate of mice than the model group (P＜0.001). Compared with the control group and the NAC group, the model group had significant increases in the serum levels of AST and ALT and the level of MDA in liver tissue, as well as a significant reduction in the level of SOD in liver tissue (all P＜0.01). The model group had a significantly higher liver pathological score than the control group and the NAC group (both P＜0.05). Both LPS and H2O2 promoted the secretion of IL-1β and IL-6 in LX2 cells, and NAC effectively inhibited the pro-inflammatory effect of H2O2 and LPS (all P＜0.05). H2O2 and LPS acted on LX2 cells and promoted the apoptosis of HL7702 cells (all P＜0.05). ConclusionLPS can promote HSC inflammation via reactive oxygen species and participates in the progression of liver failure by inducing hepatocyte apoptosis.

Establishment of Reduplicated Model of Fulminant Liver Failure and Research on Its Treatment

The effect of histone deacetylase inhibitor ACY1215 on the inflammatory response in mice with acute liver failure

[Establishment of a D-galactosamine/lipopolysaccharide Induced Acute-on-chronic Liver Failure Model in Rats].

Optimization of mouse model of fulminant hepatic failure by factorial experiment

[Liver Fibrosis Inhibits Lethal Injury Through D-galactosamine/lipopolysaccharide-induced Necroptosis].

Establishment of Lipopolysaccharide Inducing Mouse Acute Liver Iniurv and Lethal Model

A Novel Acute Lethal Liver Injury Mouse Model with Visualization of NF-κB Activity for Treatment of Severe Acute Liver Injury.

Inhibiting the expression of hepatocyte nuclear factor 4 alpha attenuates lipopolysaccharide/D-galactosamine-induced fulminant hepatic failure in mice.

The Progress to Establish Optimal Animal Models for the Study of Acute-on-chronic Liver Failure

Role and Mechanism of Hepatic Stellate Cells in the Pathogenesis of Mice with Acute-on-chronic Liver Failure

Establishment and Morphological Study of a Novel T-cell-mediated Immune Hepatic Fibrosis Model in BALB/C Mice

Protective Effect of SKLB010 Against D-Galactosamine/lipopolysaccharide-induced Acute Liver Failure Via Nuclear Factor-Κb Signaling Pathway in Macrophages

A New Murine Liver Fibrosis Model Induced by Polyhexamethylene Guanidine-Phosphate

Mefunidone ameliorates acute liver failure in mice by inhibiting MKK4-JNK pathway

Mesenchymal stem cells prolong survival and prevent lethal complications in a porcine model of fulminant liver failure

Tetrandrine Attenuates Lipopolysaccharide-Induced Fulminant Hepatic Failure in D-galactosamine-sensitized Mice.

Protection of Plasma Transfusion Against Lipopolysaccharide/ D -Galactosamine-induced Fulminant Hepatic Failure Through Inhibiting Apoptosis of Hepatic Cells in Mice

Protective effect of nicotiflorin from Nymphaea candida on D-Gal-induced acute liver injury in mice

Mycophenolate mofetil prevents lethal acute liver failure in mice induced by bacille Calmette-Guérin and lipopolysaccharide.

Establishment of Acute Liver Failure Model in Tibetan Miniature Pig and Verified by Dual Plasma Molecular Adsorption System

The Protective Effects of a Modified Xiaohua Funing Decoction against Acute Liver Failure in Mice Induced by D-Gal and LPS